Hence, we decided to investigate the impact of knocking down TOMM20 using CRISPR‐Cas9 in sarcoma cell lines and evaluate whether TOMM20 is essential for the expression of drivers of cancer aggressiveness (Fig. 5A; Fig. S6A). The gene discussed is TOMM20; the disease is cancer.